Cancer risk in users of calcium channel blockers

被引:0
|
作者
Vermes, I [1 ]
Haanen, C
Fox, C
Reutelingsperger, C
机构
[1] Med Spectrum Twente, Dept Clin Chem, Enschede, Netherlands
[2] State Univ, Dept Biochem, Maastricht, Netherlands
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:1641 / 1642
页数:2
相关论文
共 50 条
  • [1] Cancer risk in users of calcium channel blockers
    Olsen, JH
    Sorensen, HT
    Friis, S
    McLaughlin, JK
    Steffensen, FH
    Nielsen, GL
    Andersen, M
    Fraumeni, JF
    Olsen, J
    HYPERTENSION, 1997, 29 (05) : 1091 - 1094
  • [2] Cancer risk in users of calcium channel blockers - Response
    Olsen, JH
    Friis, S
    Sorenson, HT
    Steffensen, FH
    Nielsen, GL
    Olsen, J
    McLaughlin, JK
    Andersen, M
    HYPERTENSION, 1997, 30 (06) : 1642 - 1642
  • [3] Cancer risk and mortality in users of calcium channel blockers -: A cohort study
    Sorensen, HT
    Olsen, JH
    Mellemkjær, L
    Thulstrup, AM
    Steffensen, FH
    McLaughlin, JK
    Baron, JA
    CANCER, 2000, 89 (01) : 165 - 170
  • [4] Calcium channel blockers and the risk of cancer
    Rosenberg, L
    Rao, S
    Palmer, JR
    Strom, BL
    Stolley, PD
    Zauber, AG
    Warshauer, ME
    Shapiro, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (13): : 1000 - 1004
  • [5] Calcium-channel blockers and risk of cancer
    Jick, H
    LANCET, 1997, 349 (9066): : 1699 - 1700
  • [6] Calcium-channel blockers and risk of cancer
    Kritchevsky, SB
    Pahor, M
    LANCET, 1997, 349 (9062): : 1400 - 1400
  • [7] Calcium channel blockers, verapamil and cancer risk
    La Vecchia, C
    Bosetti, C
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (01) : 7 - 8
  • [8] Calcium-channel blockers and risk of cancer
    Jick, H
    Jick, S
    Derby, LE
    Vasilakis, C
    Myers, MW
    Meier, CR
    LANCET, 1997, 349 (9051): : 525 - 528
  • [9] Calcium Channel Blockers and the Risk of Cancer: A Preclinical Assessment
    Hans J. Ahr
    Ernst Bomhard
    Harald Enzmann
    Eberhard Karbe
    Harry Mager
    Erich Sander
    Gerhard Schlüter
    Cardiovascular Drugs and Therapy, 1998, 12 : 157 - 169
  • [10] Risk of suicide in users of β-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors
    Sorensen, HT
    Mellemkjær, L
    Olsen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (03) : 313 - 318